ANDA Review Documents – Paclitaxel Protein-bound Particles (ANDA 212700, Feb 03, 2022–Oct 08, 2024)

ANDA Review Documents – Paclitaxel Protein-bound Particles (ANDA 212700, Feb 03, 2022–Oct 08, 2024)

Regular price $69.00 USD
Regular price Sale price $69.00 USD
Sale Sold out
Request Contents: Complete ANDA review documents for Paclitaxel Protein-bound Particles for Injectable Suspension (albumin-bound), 100 mg/vial ANDA number: 212700 Submission date: February 03, 2022 Approval date: October 08, 2024 CMC and BE review documents Request for cost estimate before proceeding
  • Status: Pending Fast-Track Request
  • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details